Exxonmobil Investment Management Inc. TX Has $5.58 Million Stake in Zoetis Inc (ZTS)
Exxonmobil Investment Management Inc. TX decreased its position in Zoetis Inc (NYSE:ZTS) by 13.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,481 shares of the company’s stock after selling 12,146 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Zoetis were worth $5,582,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. Dynamic Technology Lab Private Ltd raised its stake in Zoetis by 7.3% in the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock worth $368,000 after acquiring an additional 401 shares during the last quarter. Balyasny Asset Management LLC raised its stake in Zoetis by 55.5% in the 2nd quarter. Balyasny Asset Management LLC now owns 44,330 shares of the company’s stock worth $2,765,000 after acquiring an additional 15,830 shares during the last quarter. BlackRock Inc. raised its stake in Zoetis by 3.9% in the 2nd quarter. BlackRock Inc. now owns 37,495,299 shares of the company’s stock worth $2,338,957,000 after acquiring an additional 1,412,829 shares during the last quarter. Quantbot Technologies LP purchased a new position in Zoetis in the 3rd quarter worth $3,972,000. Finally, Prudential PLC raised its stake in Zoetis by 4.8% in the 2nd quarter. Prudential PLC now owns 149,389 shares of the company’s stock worth $9,319,000 after acquiring an additional 6,811 shares during the last quarter. Institutional investors own 93.19% of the company’s stock.
ZTS has been the subject of a number of research analyst reports. BMO Capital Markets restated a “hold” rating and issued a $65.00 target price on shares of Zoetis in a research note on Thursday, November 2nd. Cowen set a $80.00 target price on Zoetis and gave the stock a “buy” rating in a research note on Friday, November 17th. Morgan Stanley upgraded Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research note on Wednesday, November 29th. UBS Group restated a “neutral” rating on shares of Zoetis in a research note on Friday, November 24th. Finally, Citigroup upgraded Zoetis from a “neutral” rating to a “buy” rating and set a $85.00 target price for the company in a research note on Thursday, January 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $71.28.
Shares of Zoetis Inc (NYSE:ZTS) opened at $73.91 on Thursday. The firm has a market capitalization of $36,020.00, a PE ratio of 38.90, a price-to-earnings-growth ratio of 1.91 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. Zoetis Inc has a 12-month low of $52.00 and a 12-month high of $75.47.
Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period last year, the firm earned $0.52 EPS. equities analysts anticipate that Zoetis Inc will post 2.37 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be given a dividend of $0.126 per share. This is an increase from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 0.68%. The ex-dividend date is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is currently 22.11%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with Analyst Ratings Network's FREE daily email newsletter.